about
Targeted DNA mutagenesis for the cure of chronic viral infectionsThe Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseBlood-CNS Barrier Impairment in ALS patients versus an animal modelTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future ProspectiveNanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitorsDirect nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesBrain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles.Activation of B cells by a dendritic cell-targeted oral vaccine.Novel central nervous system drug delivery systems.Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in HumansComparative manufacture and cell-based delivery of antiretroviral nanoformulations.Novel treatment strategies for brain tumors and metastases.Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem CellsNanoART, neuroAIDS and CNS drug delivery.Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review.Liposomes for brain delivery.Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.Nano-enabled delivery systems across the blood-brain barrier.Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.Nanotheragnostic applications for ischemic and hemorrhagic strokes: improved delivery for a better prognosis.Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.Inhibitory effects and actions of pentacyclic triterpenes upon glycation.Nano-ART and NeuroAIDS.Neuropharmacologic Approaches to Restore the Brain's Microenvironment.Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB).Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route.Effect of Neonatal Exposure to Poly(Ethylene Glycol)-block-Poly(Lactic Acid) Nanoparticles on Oxidative State in Infantile and Adult Female RatsFabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.Accumulation of micron sized iron oxide particles in endothelin-1 induced focal cortical ischemia in rats is independent of cell migration.Development of poly(butylene succinate) microspheres for delivery of levodopa in the treatment of Parkinson's disease.Synthesis of Biocompatible Titanate Nanofibers for Effective Delivery of Neuroprotective Agents.Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?Amelioration of Cognitive Deficit by Embelin in a Scopolamine-Induced Alzheimer’s Disease-Like Condition in a Rat Model.Nanoparticles combined with growth factors: recent progress and applications
P2860
Q24620150-EE39CB75-9993-4E0C-9C6C-D365AC135A66Q26745586-6E78AFD9-D7BF-4B3A-BC76-FEA852BE5511Q26783306-CB5007FD-13E7-4F14-BDC3-55E50067DE3AQ27026792-DDE0F44A-A808-43D6-B31E-2F92227DF911Q27690256-656723D6-B763-475D-A490-307EBC4E2018Q28075999-5D89BCFC-B879-471C-AC92-746FE740E581Q30493643-C48056AA-3E25-4992-8E8B-2B0AA30F8B39Q34194374-1D040146-6276-462A-AD77-DDA5466B93C2Q34339313-293712E2-DE46-49AA-A29F-66979BE681D7Q34797004-B9579992-DA4A-4D2E-8B5A-028815808F24Q34961530-914C7E6D-9FAF-4401-952D-5F557E3133EAQ34979404-5E532DEE-C07F-4234-AA5E-7227933E8141Q35064473-6B6BBDBD-61F7-4C8F-9BC6-F6D96B60F52CQ35529165-B352EC53-CBAA-488E-8562-3C2D3BE6A458Q35677168-D438BAC8-212E-4597-ABA0-D6C93DCAFCE6Q35734471-BF9E4F28-21D1-4F2F-9C5F-D47E31B2958AQ36052412-347A0006-F2A5-46A5-B6C7-6E70E0A6FCC4Q37274084-1D12B6B2-9038-46FC-84E3-1C434746B531Q37538776-0FAC662E-16F6-4C23-8D61-A546C0C1780DQ37667322-DCBA672F-902A-42CD-A7CD-5E62609F99EEQ38078421-2D075F35-316A-4E81-A130-35EE4A2B5C09Q38133554-11032FBB-725C-4167-87A8-45A527AC2D97Q38156382-1651708B-4FD2-4828-A356-A59812DC3CE6Q38191484-E6AEE450-9BAD-4A5F-8B7C-5364DDDEA88DQ38267991-79E97C9E-49DA-4D99-84DB-38A74872689DQ38372996-86D7255A-E4FA-47AE-B918-59A266E6FEF0Q38563967-492855CA-998F-4988-920C-E8FE17F2D064Q38823456-9BAB257D-DB2D-49AC-A4D4-5D12E646D4FCQ38879533-A294DF19-F0A7-41EE-AAAC-919EC5414FB7Q39378837-D4866377-55D7-47A2-A59F-3FD2D08513BEQ42315487-C1B08550-96B1-4164-B848-F85320C7C03AQ42730492-F4D4CDF6-E6C6-4716-80A5-29A864233BF3Q45124967-DF44CCC3-D970-46D2-A3F6-93CDF949206CQ45226946-4CFE09EF-0F6D-4183-BBC7-38C825054BB1Q45734939-A9D9E84E-A59F-4240-93A0-E4C28946947EQ47266532-19C164D3-EF7A-4C21-AAB6-CAE672864C1BQ47724056-19D196FD-C7FE-4D0B-B5B5-7BC6BA606C0EQ47736742-FD81234C-7C7A-4EDA-A1AB-014118EAFFD9Q55500833-F2905474-314F-4799-A9E7-21856D1B947CQ57377197-AF7CF4AA-667F-4D98-A772-2B011395AF52
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CNS drug delivery systems: novel approaches.
@en
CNS drug delivery systems: novel approaches.
@nl
type
label
CNS drug delivery systems: novel approaches.
@en
CNS drug delivery systems: novel approaches.
@nl
prefLabel
CNS drug delivery systems: novel approaches.
@en
CNS drug delivery systems: novel approaches.
@nl
P2093
P1476
CNS drug delivery systems: novel approaches.
@en
P2093
Adnan Azeem
Divya Vohra
Farhan J Ahmad
Gaurav K Jain
Jigar R Lalani
Nitin Jain
Roop K Khar
Shadab A Pathan
Sushma Talegaonkar
Syed M A Zaidi
P356
10.2174/187221109787158355
P577
2009-01-01T00:00:00Z